Search Results 1801-1810 of 16159 for Epilepsy (Partial Onset)
No evidence of uncontrolled seizures, central nervous system (CNS) disorders, or psychiatric disability that, judged by the investigator, is clinically ...
... {{year}} MFMER. All rights reserved. Policy: $name $name. Title: Alternate Title: Transcript: Sound Artifact. POC ID: AUD-20468569. Duration: 00:27:34. Audio ...
The purpose of this post-approval study is to further evaluate the long-term safety and effectiveness of Medtronic DBS therapy for epilepsy on seizure ...
Confirmed COVID-19: the Baseline visit must be at least 14 days from onset of signs/symptoms or positive SARS-CoV-2 test, symptomatic subjects must have ...
A Study to Determine Safety, Pharmacokinetics and Pharmacodynamics of Intravenous TKM 080301 in Neuroendocrine Tumors (NET) and Adrenocortical Carcinoma (ACC) ...
Participation eligibility · Other dementias · Repetitive head trauma · Serious infection of the brain · Parkinson's disease · Epilepsy · Cervicocranial vascular ...
... epilepsy. Dental fillings are permitted. Additional criteria for sites performing MRI cytography: Subjects who have a history of claustrophobia that cannot ...
... duration of treatment effects, requirements for additional injections, and any adverse effects. Participation eligibility. Participant eligibility includes ...
- History of seizure disorder - Any illness or condition which, based on the research team's assessment, will compromise with the patient's ability to ...
Jet lag disorder · Narcolepsy · Night leg cramps · Nightmare disorder; Nocturnal epilepsy; Non-24; Obstructive sleep apnea; Parasomnia; Pediatric obstructive ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.